Aethlon Medical
AEMD
12 hedge funds and large institutions have $1.69M invested in Aethlon Medical in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, reducing their positions, and 3 closing their positions.
12% more capital invested
Capital invested by funds: $1.51M → $1.69M (+$181K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
14% less funds holding
Funds holding: 14 → 12 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
AEMD Hedge Fund Activity: Q2 2018 in Review
12 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2018, worth a combined $1.69M — up 12% from $1.51M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of AEMD and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 4 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $62.7K. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $20K sold.
- 12 institutional investors held Aethlon Medical (AEMD) as of Q2 2018, down from 14 in Q1 2018.
- Funds reported $1.69M of Aethlon Medical stock for Q2 2018, up 12% quarter-over-quarter.
- 1 fund opened new Aethlon Medical positions in Q2 2018 and 3 closed out, a net change of -2 holders.
- The largest Aethlon Medical buyer in Q2 2018 was Susquehanna International Group, an estimated $62.7K added.
- The largest Aethlon Medical seller in Q2 2018 was Bank of New York Mellon, an estimated $20K sold.
Based on aggregated 13F filings for Q2 2018.